Quince Therapeutics (QNCX) Current Assets (2018 - 2026)
Quince Therapeutics (QNCX) posted quarterly Current Assets of $25.6 million for Q1 2026, down 24.38% year-over-year from $33.8 million in Q1 2025, and up 11.72% quarter-over-quarter from $22.9 million in Q4 2025.
Quince Therapeutics (QNCX) Current Assets (2018 - 2026) Analysis & Trends
Quince Therapeutics' Current Assets history runs 9 years deep, the most recent figure standing at $25.6 million for Q1 2026.
- In Q1 2026, Current Assets fell 24.38% year-over-year to $25.6 million; the TTM figure through Mar 2026 stood at $25.6 million (down 24.38% YoY), while the FY2025 annual figure was $22.9 million, down 48.01% from the prior year.
- Current Assets for Q1 2026 stood at $25.6 million, up from $22.9 million in the prior quarter.
- The five-year high for Current Assets was $99.4 million in Q2 2022, with the low at $22.9 million in Q4 2025.
- The 5-year median for Current Assets is $70.4 million (2024), against an average of $65.3 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets fell 4.01% in 2023, then sank 51.97% in 2025.
- Quince Therapeutics' Current Assets stood at $93.7 million in 2022, then dropped by 17.4% to $77.4 million in 2023, then tumbled by 43.14% to $44.0 million in 2024, then slumped by 48.01% to $22.9 million in 2025, then grew by 11.72% to $25.6 million in 2026.
- Business Quant data shows QNCX's Current Assets at $25.6 million in Q1 2026, $22.9 million in Q4 2025, and $29.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - | 123.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.58 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 29.20 Mn |
| Jun 30, 2025 | 37.35 Mn |
| Mar 31, 2025 | 33.83 Mn |
| Dec 31, 2024 | 44.04 Mn |
| Sep 30, 2024 | 51.72 Mn |
| Jun 30, 2024 | 63.44 Mn |
| Mar 31, 2024 | 70.44 Mn |
| Dec 31, 2023 | 77.44 Mn |
| Sep 30, 2023 | 85.17 Mn |
| Jun 30, 2023 | 88.55 Mn |
| Mar 31, 2023 | 92.49 Mn |
| Dec 31, 2022 | 93.75 Mn |
| Sep 30, 2022 | 98.28 Mn |
| Jun 30, 2022 | 99.37 Mn |
| Mar 31, 2022 | 96.35 Mn |
| Dec 31, 2021 | 111.67 Mn |
| Sep 30, 2021 | 119.43 Mn |
| Jun 30, 2021 | 135.84 Mn |